TY - JOUR
T1 - Development of a prognostic prediction support system for cervical intraepithelial neoplasia using artificial intelligence-based diagnosis
AU - Takahashi, Takayuki
AU - Matsuoka, Hikaru
AU - Sakurai, Rieko
AU - Akatsuka, Jun
AU - Kobayashi, Yusuke
AU - Nakamura, Masaru
AU - Iwata, Takashi
AU - Banno, Kouji
AU - Matsuzaki, Motomichi
AU - Takayama, Jun
AU - Aoki, Daisuke
AU - Yamamoto, Yoichiro
AU - Tamiya, Gen
N1 - Publisher Copyright:
© 2022. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology, and Japan Society of Gynecologic Oncology.
PY - 2022/9/1
Y1 - 2022/9/1
N2 - Objective: Human papillomavirus subtypes are predictive indicators of cervical intraepithelial neoplasia (CIN) progression. While colposcopy is also an essential part of cervical cancer prevention, its accuracy and reproducibility are limited because of subjective evaluation. This study aimed to develop an artificial intelligence (AI) algorithm that can accurately detect the optimal lesion associated with prognosis using colposcopic images of CIN2 patients by utilizing objective AI diagnosis. Methods: We identified colposcopic findings associated with the prognosis of patients with CIN2. We developed a convolutional neural network that can automatically detect the rate of high-grade lesions in the uterovaginal area in 12 segments. We finally evaluated the detection accuracy of our AI algorithm compared with the scores by multiple gynecologic oncologists. Results: High-grade lesion occupancy in the uterovaginal area detected by senior colposcopists was significantly correlated with the prognosis of patients with CIN2. The detection rate for high-grade lesions in 12 segments of the uterovaginal area by the AI system was 62.1% for recall, and the overall correct response rate was 89.7%. Moreover, the percentage of high-grade lesions detected by the AI system was significantly correlated with the rate detected by multiple gynecologic senior oncologists (r=0.61). Conclusion: Our novel AI algorithm can accurately determine high-grade lesions associated with prognosis on colposcopic images, and these results provide an insight into the additional utility of colposcopy for the management of patients with CIN2.
AB - Objective: Human papillomavirus subtypes are predictive indicators of cervical intraepithelial neoplasia (CIN) progression. While colposcopy is also an essential part of cervical cancer prevention, its accuracy and reproducibility are limited because of subjective evaluation. This study aimed to develop an artificial intelligence (AI) algorithm that can accurately detect the optimal lesion associated with prognosis using colposcopic images of CIN2 patients by utilizing objective AI diagnosis. Methods: We identified colposcopic findings associated with the prognosis of patients with CIN2. We developed a convolutional neural network that can automatically detect the rate of high-grade lesions in the uterovaginal area in 12 segments. We finally evaluated the detection accuracy of our AI algorithm compared with the scores by multiple gynecologic oncologists. Results: High-grade lesion occupancy in the uterovaginal area detected by senior colposcopists was significantly correlated with the prognosis of patients with CIN2. The detection rate for high-grade lesions in 12 segments of the uterovaginal area by the AI system was 62.1% for recall, and the overall correct response rate was 89.7%. Moreover, the percentage of high-grade lesions detected by the AI system was significantly correlated with the rate detected by multiple gynecologic senior oncologists (r=0.61). Conclusion: Our novel AI algorithm can accurately determine high-grade lesions associated with prognosis on colposcopic images, and these results provide an insight into the additional utility of colposcopy for the management of patients with CIN2.
KW - Artificial Intelligence
KW - Cervical Intraepithelial Neoplasia
KW - Colposcopy
KW - Deep Learning
UR - http://www.scopus.com/inward/record.url?scp=85137134312&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85137134312&partnerID=8YFLogxK
U2 - 10.3802/jgo.2022.33.e57
DO - 10.3802/jgo.2022.33.e57
M3 - Article
C2 - 35712970
AN - SCOPUS:85137134312
SN - 2005-0380
VL - 33
JO - Journal of gynecologic oncology
JF - Journal of gynecologic oncology
IS - 5
M1 - e57
ER -